Jason Miller, DPM
Foot & Ankle Surgery · Malvern, PANPI 1225023138
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.9%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Zimmer Biomet at 32.0% of the total. Among foot & ankle surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 747 payments — averaging $670.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$160K
- Treace Medical Concepts, Inc.$122K
- Bioventus LLC$61K
- Stryker$45K
- AstraZeneca$25K
- Kerecis Limited$23K
- plus $65K from 54 others
Across 17 payments — averaging $1336.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$22K
- AbbVie$1K
Across 1 payment — averaging $27,052 each. An ownership or investment interest held by the physician or an immediate family member.
- Restor3d, Inc.$27K
What the payments were for
- Royalty or licence$149,72430%
- Consulting fees$174,80435%
- Speaking & faculty fees$99,01420%
- Travel & lodging$50,54610%
- Food & beverage$25,9835%
- Gifts$8160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AccuPort$126,400
- Lapiplasty System$105,283
- Exogen Ultrasound Bone Healing System$56,913
- Kerecis Omega3 SurgiClose$42,020
- Kerecis Omega3 Marigen$35,180
- ACUMED$31,055
- ORTHOLOC 2 LAPIFUSE$25,131
- Kerecis Omega3 GraftGuide$20,040
- AccuFill$19,829
- PROstep$16,223
- LAPIPLASTY SYSTEM 1$14,341
- AUGMENT INJECTABLE$13,639
- CARTIVA SYNTHETIC CARTILAGE IMPLANT$13,639
- INBONE$13,639
- HOFFMANN$12,997
- VARIAX$12,875
- SALVATION$11,738
- GRAVITY SYNCHFIX$11,000
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$7,350
- PANTA NAIL$7,350
How this compares
$500,887 in reported general payments places this provider in the 95th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $1,527 |
| Celecoxib | 45 | $1,115 |
| Methylprednisolone | 12 | $98 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $64 |
| Meloxicam | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Malvern
- Aleksandr EmerelMalvern$53K
- Thomas MilisitsMalvern$16K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.